Related references
Note: Only part of the references are listed.The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche et al.
JOURNAL OF CROHNS & COLITIS (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease
M. Daperno et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
J. P. Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Monitoring of Thiopurine Metabolites in Patients With Inflammatory Bowel Disease-What Is Actually Measured?
Svante Vikingsson et al.
THERAPEUTIC DRUG MONITORING (2009)
Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease
A. Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: A review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease
L. Y. Kwan et al.
DIGESTIVE AND LIVER DISEASE (2008)
Clinical pharmacology and pharmacogenetics of thiopurines
Srikumar Sahasranaman et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange et al.
JOURNAL OF CROHNS & COLITIS (2008)
Dose-dependent influence of 5-aminosalicylates on thiopurine metabolism
Nanne K. H. de Boer et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease:: results from a randomized, controlled, open trial
Max Reinshagen et al.
CLINICAL CHEMISTRY (2007)
Thiopurine-induced liver injury in patients with inflammatory bowel disease:: A systematic review
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Thiopurine methyltransferase activity in Spain:: A study of 14,545 patients
Javier P. Gisbert et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease:: Long-term follow-up study of 394 patients
Javier P. Gisbert et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease
U. Hindorf et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: A meta-analysis
MT Osterman et al.
GASTROENTEROLOGY (2006)
Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy
T Dervieux et al.
CLINICAL CHEMISTRY (2005)
6-thioguanosine diphosphate and triphosphate levels in red blood cells and response to azathioprine therapy in Crohn's disease
MF Neurath et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
Thiopurine methyltransferase activity in the inflammatory bowel disease.: A study on 7046 Spanish patients
JP Gisbert et al.
MEDICINA CLINICA (2005)
Thiopurine Methyltransferase Activity Influences Clinical Response to Azathioprine in Inflammatory Bowel Disease
Carmen Cuffari et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Pharmacogenomics and IBD - TPMT and thiopurines
WJ Sandborn
INFLAMMATORY BOWEL DISEASES (2004)
The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease
BA Goldenberg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease
S Wright et al.
GUT (2004)
Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease
JP Achkar et al.
INFLAMMATORY BOWEL DISEASES (2004)
Drug interaction between infliximab and azathioprine in patients with Crohn's disease
X Roblin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Individualized therapy with azathioprine or 6-mercaptopurine by monitoring thiopurine methyl-transferase (TPMT) activity
JP Gisbert et al.
REVISTA CLINICA ESPANOLA (2002)
Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease
A Ansari et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2002)
Relevance of thiopurine methyltransferase activity in inflammatory bowel disease patients maintained on low-dose azathioprine
S Campbell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease
PW Lowry et al.
GUT (2001)
Determination of thiopurine methyltransferase activity in human erythrocytes by high-performance liquid chromatography:: Comparison with the radiochemical method
C Menor et al.
THERAPEUTIC DRUG MONITORING (2001)
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease
C Cuffari et al.
GUT (2001)
Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease
J Belaiche et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2001)
Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease
MC Dubinsky et al.
GASTROENTEROLOGY (2000)
Share Paper
